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The ability of basic leucine zipper transcription fac-
tors for homo- or heterodimerization provides a para-
digm for combinatorial control of eukaryotic gene
expression. It has been unclear, however, how facul-
tative dimerization results in alternative DNA-bind-
ing repertoires on distinct regulatory elements. To
unravel the molecular basis of such coupled prefer-
ences, we determined two high-resolution structures
of the transcription factor MafB as a homodimer and
as a heterodimer with c-Fos bound to variants of the
Maf-recognition element. The structures revealed
several unexpected and dimer-specific coiled-coil-
heptad interactions. Based on these findings, we
have engineered two MafB mutants with opposite
dimerization preferences. One of them showed a
strong preference for MafB/c-Fos heterodimeriza-
tion and enabled selection of heterodimer-favoring
over homodimer-specific Maf-recognition element
variants. Our data provide a concept for transcription
factor design to selectively activate dimer-specific
pathways and binding repertoires.
INTRODUCTION
The transcription of genes is a highly regulated combinatorial
process that is mediated by large and dynamic multicomponent
protein assemblies such as the enhanceosome (Ogata et al.,
2003; Panne, 2008; Reme´nyi et al., 2004). These assemblies
generally involve several distinct transcription factors that act
as homo- or hetero-oligomeric assemblies on specific cis-regu-
latory DNA promoter and enhancer sites, ultimately modifying
the local chromatin architecture to activate the polymerase II
machinery on the target promoter site. Their ability to assemble
with several alternative binding partners allows many transcrip-466 Structure 22, 466–477, March 4, 2014 ª2014 Elsevier Ltd All rightion factors to be involved in the combinatorial transcription of
different genes, leading to unrelated, sometimes even antago-
nistic, functional readouts or distinct cell fate decisions (Sieweke
and Graf, 1998). Understanding the basic mechanisms of vari-
able protein assembly in gene transcription is essential for the
rationalization of genotypic and phenotypic effects during devel-
opment and pathology. This knowledge of the underlying molec-
ular parameters could ultimately be used to engineer altered
transcription circuits.
An important example of such alternative transcription factor
assemblies is the basic leucine zipper (bZip) transcription factor
family, which binds to a variety of related cyclic AMP-response
and 12-O-tetradecanoate-13-acetate-response element (CRE/
TRE) DNA-recognition sites both as homo- or heterodimeric
complexes (Miller, 2009). Their large combinatorial versatility
is established by sequence-specific coiled coil assemblies
within the long leucine zipper (Zip) segment, which is next to
the basic region (BR) that functions as a direct DNA-binding
segment. The molecular determinants of coiled-coil interactions
in bZip transcription factors have been extensively studied by
biophysical, structural, and computational approaches and
engineering experiments (Grigoryan and Keating, 2008; Miller,
2009; Vinson et al., 2006). Available data, however, are limited
to studies of bZip factors in the absence of DNA and using
dimer pairs with similar DNA-binding preferences, such as
members of the c-Jun/c-Fos family that have a common
preference for CRE/TRE. In essence, these data indicate that
typical leucine zipper interfaces are formed by hydrophobic
knob-into-holes interactions of residues from heptad positions
a and d and additional facultative electrostatic interactions
between residues from positions e and g. Collectively, the
absence/presence of suitable residues in those positions allow-
ing the formation of these interactions is thought to govern
specificity for the ability of assembling either into homo- or
heterodimers with other bZip transcription factors. Since the
overall arrangement in leucine zippers is structurally conserved,
available experimental structural data have limited power to
predict those interactions in related bZip transcription factor
assemblies.ts reserved
Figure 1. Binding of MafB/c-Fos to T-MARE
Variants
(A) MafB and c-Fos constructs used for analysis,
colored in cyan (MafB) and chocolate (c-Fos).
The domain boundaries are indicated, as observed
in the structures of the respective complexes
(cf. Figure 2).
(B) Sequences of TRE, conventional T-MARE(a),
and T-MARE variants (b and g). Color codes:
flanking MARE sequences (positions 6 to 4, +4
to +6), green; TRE (positions 3 to +3), yellow,
except central position 0, orange; MARE(b, g)
mutations are indicated in red.
(C) EMSA of 4 pmol MafB in the presence of
various concentrations (0.25, 0.5, 1, 2, 4, 8, 16, 32,
and 64 pmol, from left to right, increasing
concentrations indicated above) of c-Fos on
T-MARE(a) (left panel), T-MARE(b) (center panel),
and T-MARE(g) (right panel). Equimolar concen-
tration of MafB and c-Fos is indicated by asterisk.
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MafB/c-Fos Assembly-Induced DNA Binding ProfileHowever, a direct comparison of alternative bZip complexes
with assembly-specific preferences for distinct DNA-recognition
elements has not been performed and could identify the determi-
nants of binding repertoire and target gene selection (Miller,
2009; Yamamoto et al., 2006). To investigate bZip assembly-
dependent DNA-binding site selection, we have studied two pro-
totype bZip transcription factors with different DNA-binding
recognition sites and the ability to heterodimerize: MafB and
c-Fos (Kataoka et al., 1994; Kerppola and Curran, 1994b; New-
man and Keating, 2003). MafB plays important roles in tumori-
genesis, differentiation, and several developmental processes
such as hematopoiesis (Aziz et al., 2009; Eyche`ne et al., 2008;
Sarrazin et al., 2009; Tillmanns et al., 2007). In particular in mac-
rophages, MafB is constitutively expressed, whereas c-Fos is
transiently induced upon pathogen challenge or cytokine stimu-
lation and has immunomodulatory functions in macrophages
and dendritic cells (Amit et al., 2009; Introna et al., 1986; Koga
et al., 2009; Pulendran et al., 2010). In terms of overall domain
structure, MafB is a member of the Maf subfamily of bZip tran-
scription factors, which share an additional helical bundle region,
known as the extended homology region (EHR), preceding the
BR (Kataoka et al., 1994; Kerppola and Curran, 1994a; Kusunoki
et al., 2002; Figure 1A). MafB requires a long DNA-recognition
sequence known as theMaf-recognition element (MARE) that in-
cludes a three-base extension of the central 7 or 8 bp CRE/TRE
core motif of the canonical bZip recognition element (Yamamoto
et al., 2006). Here we have focused on MARE sequences with a
7 bp TRE-type core (T-MARE; Figure 1B). Interestingly, MAREs
that have been found in confirmed target genes are highly
degenerate in both the TRE core motif and the two flanking re-
gions (Yamamoto et al., 2006). Themajor reported heterodimeric
bZip binding partner of MafB is c-Fos (Kataoka et al., 1994; Ker-
ppola and Curran, 1994b; Newman and Keating, 2003) (Fig-
ure 1A). In contrast to MafB, c-Fos does not homodimerize
and its specific DNA interactions are limited to the central
CRE/TRE (Glover and Harrison, 1995; Hai and Curran, 1991),
thus the presence of the flanking segments of the MARE are
not required for c-Fos binding.Structure 22,RESULTS AND DISCUSSION
Structure Determination of Distinct MafB2 and
MafB/c-Fos DNA Complexes
To determine the molecular parameters that govern specific
binding of the homodimeric MafB2 and heterodimeric MafB/
c-Fos complexes to the T-MARE motif, we investigated
T-MARE variants with an expected preference for the homodi-
meric MafB2 or the heterodimeric MafB/c-Fos assembly. We
used the following oligonucleotides (Figure 1B): (1) a canonical,
palindromic T-MARE motif (50-TGCTGACTCAGCA-30) with
an intact TRE site and two flanking MARE extensions (under-
lined), referred to as T-MARE(a); (2) an asymmetric oligonucleo-
tide (50-TGAGTCAGCA-30) with only one MARE extension
(underlined) flanking the central TRE, referred to as T-MARE(b),
to promote MafB/c-Fos heterodimerization; and (3) a third
oligonucleotide (50-TGCCTACTAGGCA-30) that has two un-
changed MARE extensions and an altered TRE core motif
(changes in italics), referred to as T-MARE(g), to promote
MafB2 homodimerization.
As shown by an electrophoretic mobility shift assay (EMSA), at
an equimolar ratio of MafB and c-Fos, both complexes—homo-
dimeric MafB2 and heterodimer MafB/c-Fos—are found at com-
parable concentrations when bound to T-MARE(a). Changing
the ratio of the two transcription factors by c-Fos titration re-
sulted in a shift in complex formation: homodimeric MafB2 in
the presence of excess MafB and heterodimeric MafB/c-Fos in
the presence of excess c-Fos. Under identical experimental con-
ditions, T-MARE(b) showed a strong preference for MafB/c-Fos,
and T-MARE(g) bound only homodimeric MafB2 with no signifi-
cant amount of heterodimeric MafB/c-Fos detected (Figure 1C).
Using a previously established purification protocol (Textor
et al., 2007), we first determined the crystal structure of homodi-
meric MafB2 with a 20 bp DNA duplex, encompassing the
T-MARE motif, at 2.9 A˚ resolution (Table 1 and Figure 2A). To
obtain a pure heterodimeric MafB/c-Fos complex suitable for
crystallization, we exploited the established binding preference
of heterodimeric MafB/c-Fos for T-MARE(b) (Figure 1C), allowing466–477, March 4, 2014 ª2014 Elsevier Ltd All rights reserved 467
Table 1. Data Collection, Phasing, and Refinement Statistics
MafB/c-Fos/T-MARE(b) MafB2/T-MARE(a)
Native Iodine Derivatized Native
Data Collection
Space group P62 P22121
Cell dimensions
a, b, c (A˚) 146.7, 146.7, 51.2 41.2, 49.8, 170.4
Resolution (A˚) 47.4–2.3 (2.42–2.3)a 64.0–3.2 (3.5–3.2)a 170.4–2.9 (3.0–2.9)a
Rsym or Rmerge 5.2 (32.0)
a 10.0 (19.9)a 9.8 (32.9)a
I/sI 10.1 (2.4)a 6.1 (1.9)a 6.8 (2.2)a
Completeness (%) 99.5 (99.3)a 97.2 (81.4)a 100 (99.7)a
Redundancy 11.9 (10.2)a 42.3 (28.2)a 6.9 (6.6)a
Refinement
Resolution (A˚) 47.4–2.3 64.0–3.2
Reflections (n) 28,122 8,174
Rwork/Rfree 22.8/25.6 23.5/27.5
Atoms (n)
Protein 1,329 1,588
DNA 650 799
Others 177 72
B-factors
Protein 45.7 38.4
DNA 41.0 32.3
Others 45.6 31.9
Rmsd
Bond lengths (A˚) 0.009 0.007
Bond angles () 1.39 1.26
aValues in parentheses are for the highest-resolution shell.
Structure
MafB/c-Fos Assembly-Induced DNA Binding Profilethe separation of a highly pure MafB/c-Fos/T-MARE(b) complex
(Figure S1 available online) and its X-ray structure determination
at 2.3 A˚ resolution.
In the homodimeric MafB2/T-MARE complex, each MafB pro-
tomer symmetrically binds to one of the two T-MARE half-sites
(Figure 2A). The two MafB molecules show a virtually identical
overall conformation, reflected by a root-mean-squares devia-
tion (rmsd) of 1.7 A˚ for 92 common residues. Based on this struc-
ture, we have defined three sequence segments for each MafB
polypeptide chain (Figures 1A and 2A): the first represents the
N-terminal EHR, which folds into a small three-helical bundle
domain or helix-turn-helix motif (residues 211–237); the second
sequence segment represents the BR that binds into the major
groove of each T-MARE half-binding site (residues 238–261);
the third segment forms the Zip region that establishes the
homodimeric MafB assembly by a long, left-handed coiled coil
(residues 262–305). The Zip and BR together constitute the basic
zipper (bZip) region, which folds into a long, uninterrupted 75-
residue helix with more than 20 helical turns.
In contrast to the MafB2/T-MARE complex, the heterodimer
MafB/c-Fos/T-MARE(b) complex is asymmetric, owing to the
two different protein ligands (MafB, c-Fos) and the lack of one
of the two MARE extensions in the DNA motif (Figure 2B).
MafB is bound to the remaining T-MARE half-site, whereas
c-Fos binds to the opposite TRE half-site without the T-MARE468 Structure 22, 466–477, March 4, 2014 ª2014 Elsevier Ltd All righextension. Similarly to MafB, c-Fos comprises a BR (residues
137–160) involved in DNA binding, followed by the Zip segment
(residues 161–200) that assembles with the equivalent MafB Zip
segment (residues 262–301) into a heterodimeric coiled coil. In
contrast to MafB, c-Fos does not comprise an additional EHR.
Recognition of Distinct MARE Variants by MafB2 versus
MafB/c-Fos
As we expected different DNA-binding preferences for MafB
and c-Fos, we systematically analyzed the MafB2/T-MARE and
MafB/c-Fos/T-MARE(b) complexes in terms of the kind of
molecular protein/DNA interactions observed in the two struc-
tures. Indeed, they revealed remarkable differences in the
arrangement of the base-specific DNA interactions, formed
with the central TRE motif and the flanking MARE nucleotides.
In the structure of the heterodimeric MafB/c-Fos/T-MARE(b)
complex, the observed protein-DNA interactions are highly
asymmetric and are caused by mostly unrelated interactions
from the two protein ligands (Figures 2B and 3). Most of the
MafB-mediated interactions with the DNA half-site, which
contain the remaining T-MARE extension, are identical to
those found in the MafB2/T-MARE complex (Figure S2). An
exception is R256 from MafB that provides an additional
base-specific interaction via a bidentate hydrogen bond pattern
with guanine in the central position 0 of the heterodimericts reserved
Figure 2. Overall Structure of MafB2/T-MARE(a) and MafB/c-Fos/
T-MARE(b) Complexes
Overall structure of (A) MafB2/T-MARE(a) and (B) MafB/c-Fos/T-MARE(b)
complexes. Color coding: MafB, cyan; c-Fos, chocolate; color codes of
T-MARE(a)/T-MARE(b) are as in Figure 1. Protein structures are shown as
ribbons, bound DNA is shown in combined stick and semitransparent surface
representation. Protein structural segments (Zip, BR, EHR), helices of the EHR,
and protein sequence termini are indicated. The T-MARE- and T-MARE(b)-
containing oligonucleotide sequences used for crystallization are shown
below, with color codes as in Figure 1.
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MafB/c-Fos Assembly-Induced DNA Binding ProfileMafB/c-Fos/T-MARE(b) complex (Figure 3). By contrast, the
equivalent c-Fos residue (R155) is only involved in interactions
with the DNA phosphate backbone. In addition, a total of six
residues of the BR from c-Fos are involved in T-MARE(b) interac-
tions that are mostly restricted to the central TRE of T-MARE(b).
Only one c-Fos residue, N147, is involved in base-specific inter-
actions by hydrogen bonds to C(+2) and T(3), which are located
on opposite strands within the same TRE half-site. N147 from
c-Fos is structurally equivalent to N248 from MafB, which is
one of two MafB key residues for base-specific interactions
with T-MARE. Remarkably, a spatial difference of the asparagine
side chain by about 2 A˚ is sufficient to allow different base-spe-
cific interactions either with the central TRE (mediated by c-Fos)
or with the extended T-MARE (mediated by MafB; Figures 3C,
3D, and S2). The other c-Fos residue, R143, which has a
conserved structural MafB equivalent involved in base-specific
interactions (R244), does not bind to any T-MARE(b) base.
In contrast to the MafB/c-Fos/T-MARE(b) complex, the
protein-DNA interactions observed in the homodimeric MafB2/
T-MARE complex are almost identical in the two MafB proto-
mers, reflecting the symmetric nature of the overall complex
(Figures 2A and S2). Whereas interactions with the DNA phos-
phate backbone are distributed over the complete T-MARE,
base-specific interactions by residues R244 and N248 are
restricted to the G/C positions ±4 and ±5 of the two T-MARE-
specific, extended three-base elements. Interestingly, no resi-
dues from the EHR are involved in any specific side-chain-
mediated T-MARE interactions.
A comparative analysis of the protein interactions with the
DNA phosphate backbone of the two complexes revealed that
the majority of the residues contributing to these interactionsStructure 22,are not conserved in MafB and c-Fos (Figure 3B). TwoMafB res-
idues, R243 and Y251, which contribute to DNA-backbone
recognition of the extended T-MARE base triplet by hydrogen
bonds, are substituted with small hydrophobic residues in
c-Fos (I142, A150). Conversely, a c-Fos residue (R159) that binds
to the phosphate group of one of the central TRE bases is re-
placed in MafB with a small hydrophobic amino acid (V260)
that does not have the ability to bind to DNA, thus shifting the
overall layout of MafB-mediated DNA phosphate interactions
toward the extended T-MARE base triplet. However, as the
key MafB residues responsible for base-specific interactions
are conserved in c-Fos (MafB/c-Fos, R244/R143, and N248/
N147), our structural data indicate that the ability to form a
different set of additional phosphate-mediated DNA backbone
interactions, namely mediated by MafB-specific residues R243
and Y251, is an important parameter for the different preferred
DNA recognition sequences by c-Fos and MafB, represented
by TRE and the extended T-MARE half-sites, respectively.
Together these structural data reveal the molecular basis of
distinct DNA-binding site preferences for MafB2 homodimers
and MafB/c-Fos heterodimers.
Molecular Parameters Permitting FacultativeMafB2 and
MafB/c-Fos Assembly
We next analyzed the structures of the MafB2 and MafB/c-Fos
complexes to identify the molecular parameters that determine
homo- versus heterodimer formation. The overall coiled-coil
arrangement in MafB2 and MafB/c-Fos extends over six com-
plete heptad repeats (Figure 4), generating extensive interface
surfaces (1,275 A˚2 in MafB2, 1,058 A˚
2 in MafB/c-Fos). Most of
the coiled-coil interactions are found within the four central
heptad repeats II–V of both complexes, whereas the flanking re-
peats I and VI are more loosely arranged (Figures 4 and S3). In
both protein assemblies, most of the specificity-determining in-
teractions are found in repeats II, III, and V.
Repeat position d in the first four repeats of MafB is a highly
conserved leucine, which is the most common amino acid in
this position in canonical coiled coils (Miller, 2009). However, in
repeat V, it is occupied by an unusual aromatic amino acid
(Y294). In the homodimeric MafB2 complex, the phenyl side
chains of the same residue from the two MafB helices point
away from each other (Figure 4C). In each of the MafB repeats
I, II, and V, position a is represented by positively charged
residues, which is rare in other bZip coiled coils. Two of these
residues contribute to the two salt-bridge pairs of the MafB2
homodimer, along with negatively charged residues from
neighboring g positions: E269–K270 (heptad II) and E290–R291
(heptad V).
Surprisingly and in marked contrast to most other coiled-coil
arrangements in bZip transcription factors (Miller, 2009; Vinson
et al., 2006), there are no specific interactions between any
residues from heptad positions e and g. These observations sug-
gest that many of the heptad interactions found in the homodi-
meric MafB leucine zipper are specific for MafB and deviate
from the type of interactions found in other bZip transcription
factors. This finding is further supported by a comparison of
the MafB2/T-MARE complex with a recent structure of protein/
DNA complex of MafG (Figures S4A–S4C; Kurokawa et al.,
2009), which is member of the related family of small Maf466–477, March 4, 2014 ª2014 Elsevier Ltd All rights reserved 469
Figure 3. Protein-DNA Interactions in the Heterodimeric MafB/c-Fos/T-MARE(b) Complex
Color codes are as in Figure 1; oxygen and nitrogen atoms are in red and blue, respectively.
(A) Schematic representation, highlighting base-specific interactions in bold and remaining hydrogen-bond interactions in regular characters. Hydrogen bonds
are indicated with dashed arrows.
(B) Structure-based sequence alignment of the BR from MafB and c-Fos. Residues involved in base-specific interactions, red; residues involved in interactions
with the phosphate backbone of T-MARE or T-MARE(b), green.
(C and D) Ribbon representation emphasizing (C) c-Fos/DNA interactions and (D) MafB/DNA interactions. The second protein partner is shown in gray in each
presentation. The view of (C) is similar to that shown in Figure 2. The view of (D) is rotated by about 180 with respect to (C) and Figure 2, to allow complete
visualization of protein/DNA interactions. Dashed lines indicate hydrogen bonds; contributing protein residues and nucleotides are labeled. For reasons of clarity,
additional van-der-Waals interactions are not indicated.
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MafB/c-Fos Assembly-Induced DNA Binding Profiletranscription factors that shares the same domain structure
responsible for coiled-coil-mediated protein-protein assembly
and DNA binding, but lacks a transactivation domain (Eyche`ne
et al., 2008). Although the interface positions (a, d, e, and g) of
the coiled-coil region fromMafB andMafG share 50% sequence
identity (12/24 residues from six heptads), only one specific
interaction—E269–K270 in MafB—is structurally conserved,
whereas all further coiled-coil interaction pairs are specific either
for MafG or MafB. Another structure of MafA (Lu et al., 2012), a
member of the long Maf family, was not included into this com-
parison since many amino acid side chains in the leucine zipper
region were only partially built.
In the c-Fos heptad repeat sequence, all d positions are repre-
sented by leucine residues. Positions a of repeats III and V,
similar to our observations in MafB, are positively charged
residues. K176 (c-Fos) from the a position of repeat III forms
an additional hydrogen bond with Q276 (MafB) from the preced-470 Structure 22, 466–477, March 4, 2014 ª2014 Elsevier Ltd All righing g position, which is not observed in the MafB2 coiled coil.
However, in homodimeric MafB2 such an interaction is not
possible, as heptad III is the only one with a small hydrophobic
residue (V277) in the respective a position (Figures 4C and 4D).
However, as each of the a positions in repeat V of MafB and
c-Fos contains a positively charged residue and the g positions
from the preceding heptad are represented by a glutamate, a
pair of salt bridges—E290 (MafB)–K190 (c-Fos) and R291
(MafB)–E189 (c-Fos)—is formed that is in a virtually identical
position to the symmetric pair of salt bridges E290–R291 in the
MafB2 coiled coil. For the other symmetric salt-bridge pair in
the homodimeric MafB2 assembly, E269–K270, only one of the
two equivalent c-Fos residues is a charged residue (E168), and
so only one salt bridge can be formed in the heterodimeric
MafB/c-Fos coiled coil: E168 (c-Fos)–K270 (MafB). Thus, the
total number of specific salt-bridge interactions from residues
of heptad positions a and g in the heterodimeric MafB/c-Fosts reserved
Figure 4. Comparison of Coiled-Coil Interactions in Homodimeric MafB2 and Heterodimeric MafB/c-Fos
(A–C) Ribbon presentation of (A) MafB2 and (B) MafB/c-Fos coiled-coil interactions. (C) Zoom into coiled-coil interactions of central heptads II, III, IV, and V,
indicating the two-layered structure in each heptad. Side-chains of residues of positions a and g (first layer) and positions d and e (second layer) are shown by
sticks and dot representation. Residue identities of MafB (left panels) and c-Fos (right panels) are indicated (bold, when involved in specific hydrogen-bond
interactions in one or both of the two protein/DNAcomplexes). Color codes in (A)–(C) are as in Figure 2. Residues that are in potential hydrogen bond distances are
connected with dashed lines.
(D) Structure-based sequence alignment of heptads I–VI. Negatively, positively, and uncharged polar residues involved in specific coiled-coil interactions are
colored in red, blue, and green, respectively. Residues that are involved in specific heptad interactions are underlined. MafB mutants E269R and V277N are
indicated.
Structure
MafB/c-Fos Assembly-Induced DNA Binding Profilecomplex is four, like in the homodimeric MafB2 complex. Of
these, three are structurally conserved in both bZip assemblies.
Like in the homodimeric MafB2 complex, no single, specific
interaction between positions e and g is found in the heterodi-
meric MafB/c-Fos complex. In addition, an unusual specific
interaction is formed between Y294 (MafB) from position d in
heptad V and E194 (c-Fos) from position e in heptad V.
A comparison of the specific heptad interactions found in the
c-Fos/MafB/T-MARE(b) and in the c-Fos/c-Jun/TRE complexesStructure 22,(Glover and Harrison, 1995) directly demonstrates a significantly
larger number of interactions by heptad positions a–g and e–g in
the latter assembly (Figures S4E and S4F). In contrast to bZip
complexes with extendedMARE-type DNA recognition specific-
ities (MafB, MafG), in the c-Fos/c-Jun complex there are no pre-
dictable specific interactions missing (Grigoryan et al., 2009;
Newman and Keating, 2003). None of the five identified heptad
interactions from the e–g positions in the c-Fos/c-Jun complex
is found in the heterodimeric c-Fos/MafB complex. Since the466–477, March 4, 2014 ª2014 Elsevier Ltd All rights reserved 471
Figure 5. Design and Experimental Validation of Heterodimer (E269R)- and Homodimer (V277N)-Promoting MafB Versions
(A and B) Structural models of MafB mutant (A) E269R and (B) V277N (cf. Figure 4), based on the homodimeric MafB2/T-MARE(a) complex (left) and the MafB/
c-Fos/ T-MARE(b) complex (right). The models have been generated with the software PyMOL (http://www.pymol.org) and the most common side chain rotamer
of each mutated residue is shown. A predicted repulsive arrangement of two positively charged residues, R269 and K270, of the MafB (E269R) mutant in the
MafB2 homodimer arrangement, emphasized by a red cross, and a predicted attractive interaction between R269 of the MafB (E269R) mutant and E173 from
c-Fos in theMafB/c-Fos heterodimer arrangement are indicated. The view is from the N terminus to the C terminus in each heptad. Hydrogen bonds are indicated
by dashed lines (experimental structures, black; mutant models, dark green). Color codes are as in Figure 2, except carbon atoms of mutated residues are green.
(C) Differential interaction of MafB (wt), MafB (E269R), and MafB (V277N) with c-Fos in macrophages. Flag-tagged wt or MafB mutants were expressed together
with c-Fos in MafB-deficient Maf-DKOmacrophages (Aziz et al., 2009). Protein interactions were analyzed by immunoprecipitation of c-Fos followed byWestern
blot detection of MafB (left panel) or immunoprecipitation of MafB followed by Western blot detection of c-Fos (right panel).
Structure
MafB/c-Fos Assembly-Induced DNA Binding ProfileDNA-binding preferences for c-Fos/c-Jun and c-Fos/MafB are
different, proper heterodimeric bZip assembly involving c-Fos
via the underlying specific coiled-coil interactions permits selec-
tive recognition of specific cognate DNA motifs.
Designed MafB Mutants with Altered Dimerization
Properties and DNA-Binding Profile
We used this precise knowledge about the molecular parame-
ters that support distinct MafB2 and MafB/c-Fos dimerization
in the presence of different MARE variants to design structure-
based MafB mutants with altered dimerization preferences. To
engineer a MafB version that is expected to favor heterodimeri-
zation with c-Fos, at the expense of the ability for homodimeriza-
tion, we mutated E269 from the g position in heptad II into an
arginine. We predicted that this MafB version would generate a
repulsive interaction between K270 and the additional positive
charge introduced in residue 269, and therefore that it would
lose the ability to form the specific homodimeric salt-bridge472 Structure 22, 466–477, March 4, 2014 ª2014 Elsevier Ltd All righinteraction observed in the MafB2 complex (Figures 4A, 4C,
and 5A). As the residue equivalent to K270 in MafB is replaced
by a threonine in c-Fos (Figure 4D), we reasoned that this muta-
tion should have no negative effect on heterodimeric MafB/
c-Fos complex formation. By contrast, we predicted that the
E269R mutant could engage in an attractive interaction with
E173 of c-Fos in the MafB/c-Fos heterodimer. Our prediction
that the MafB (E269R) mutant would favor heterodimeric MafB/
c-Fos assembly was confirmed by coimmunoprecipitation data
showing an increased ability of the mutant to interact with
c-Fos (Figure 5C). Furthermore, EMSA analysis revealed that
even at a 16-fold excess of MafB over c-Fos, this mutant could
still mediate heterodimer formation and, at equimolar ratios, re-
sulted in almost exclusive MafB/c-Fos complex formation with
only trace amounts of the homodimeric MafB2. This is in contrast
to the wild-type (wt) protein that does not form heterodimers in
the presence of excessMafB and forms both types of complexes
at equimolar ratios (Figure 6).ts reserved
Figure 6. MARE Variant Binding Properties
of MafB (E269R) and MafB (V277N) Mutants
EMSA assays of 4 pmol MafB (wt), MafB (V277N),
or MafB (E269R) in the presence of increasing
c-Fos concentrations (0, 0.25, 0.5, 1, 2, 4, 8, 16,
32, and 64 pmol, from left to right) on T-MARE(a)
and T-MARE(b). Equimolar concentration of MafB
and c-Fos is indicated by asterisk. The titrations on
T-MARE(g) were performed in absence of c-Fos,
with increasing amounts (0.25, 0.5, 1, 2, 4, 8, 16,
32, and 64 pmol) of MafB (wt) or mutant proteins.
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MafB/c-Fos Assembly-Induced DNA Binding ProfileTo engineer a MafB version with a preference for homodime-
rization, we mimicked known coiled coil bZip transcription factor
assemblies that contain several glutamine/asparagine pairs with
mixed donor/acceptor abilities of the two residues in neighboring
g and a heptad positions (Schumacher et al., 2000). This type of
residue pair allows the formation of a unique, stable assembly
layer via aQ-N-N-Q hydrogen bondwire, maximizing the number
of possible lateral hydrogen bonds per heptad repeat. Such
an interaction is observed neither in the homodimeric MafB2
assembly nor in the heterodimeric MafB/c-Fos complex. By
mutating V277 of MafB into an asparagine, we designed such
a motif allowing the formation of a Q276-N277-N277-Q276
hydrogen bond wire in the homodimeric MafB2, but not in the
heterodimeric MafB/c-Fos complex (Figure 5B). Consistent
with a stabilization of homodimeric interactions, we expected
this mutant to prefer homodimer rather than heterodimer forma-
tion under conditions in which both interactions are equally
possible. This prediction was confirmed by coimmunoprecipita-
tion experiments, in which MafB (V277N) showed stronger
homodimerization preference than MafB (wt) protein (Figure 5C)
and EMSA on a T-MARE, in which MafB (V277N) almost exclu-
sively formed homodimers and no MafB/c-Fos complexes,
even at a 20-fold excess of c-Fos (Figure 6). Taken together,
this study shows that, by making use of structural leucine zipper
interaction data, it is possible to alter the balance of homo- and
heterodimeric MafB complexes in the presence of the same
T-MARE sequence by introducing additional targeted attractive
or repulsive interactions.
Based on our findings of altered homo- and heterodimeric
assembly properties, we further investigated to what extent
these MafB mutants could select for different T-MARE motifs.
The MafB (E269R) variant indeed showed strong differential
activity on T-MARE(g)- and T-MARE(b)-binding sites. It required
more than 10-fold higher concentrations than MafB (wt) to
exhibit detectable binding as a homodimer to homodimer-pro-
moting T-MARE(g) (Figure 6) but showed exclusive heterodimerStructure 22, 466–477, March 4, 2014formation on heterodimer-promoting
T-MARE(b), even at residual c-Fos con-
centrations (Figure 6). Consistent with
this, in the presence of c-Fos, MafB
(E269R) showed a 5-fold higher transacti-
vation of a synthetic T-MARE(b) reporter
construct than the wt protein and a
reduced activity on a T-MARE(g) reporter
construct (Figure 7A). To test whether
these observations would lead to aselective and preferential activation of T-MARE(b)-containing
promoters when both MARE variant binding sites are available,
we established a competitive transactivation assay with a
T-MARE(g)-promoter-driven Renilla luciferase reporter and a
T-MARE(b)-promoter-driven Firefly luciferase reporter, which
can be individually quantified in the same cell extract. When
transfecting both reporters together with either MafB (wt) or
MafB (E269R), we observed thatMafB (wt) showed a strong pref-
erence for T-MARE(g) promoter activation even in the presence
of c-Fos, whereasMafB (E269R) strongly selected for T-MARE(b)
promoter activation. As c-Fos is present endogenously in the
transfected cells (Figure S5), this effect was already observed
with transfection of MafB (E269R) only and further increased
upon cotransfection of exogenous c-Fos (Figures 7B and S5).
Together these data indicate that a single amino acid variation
in MafB can induce a strong shift from activating T-MARE(g)-
to T-MARE(b)-containing promoters, and thus select both nega-
tively against MafB activity on T-MARE(g) and positively forMafB
activity on T-MARE(b) sites.
However, when we investigated the MafB (V277N) mutant
(Figure 5B), we did not observe a comparable effect on prefer-
ential T-MARE(g)-binding site selection (Figure 6), possibly
because the T-MARE(g) variant already strongly favors homo-
dimer binding that may be difficult to further enhance. The bind-
ing of thisMafB variant to the heterodimer-promoting T-MARE(b)
site (Figure 6) was also unchanged. This finding was expected,
as unlike the MafB (E269R) mutant, the MafB (V277N) mutant
does not generate any predicted repulsive interactions in the
MafB/c-Fos heterodimeric complex. This observation was fur-
ther confirmed in transactivation assays, in which the MafB
(V277N) mutant showed no significant difference to the wt pro-
tein on synthetic T-MARE(g) and T-MARE(b) reporters (Fig-
ure 7C). Although the MafB (V277N) mutant shows preferential
homodimer formation on bipotential T-MARE(a) sites that can
equally accommodate MafB2 homodimers and MafB/c-Fos het-
erodimers (Figure 6, top panels), it does not select for preferentialª2014 Elsevier Ltd All rights reserved 473
Figure 7. c-Fos-Dependent Transactivation Activity of MafB (wt), MafB (E269R), and MafB (V277N) on T-MARE(b) and T-MARE(g) Sites
(A and B) Vectors for MafB (wt) or MafB (E269R) (A) or MafB (V277N) (B) expression were transfected in HEK293 cells line with multimerized MARE(b) (left) or
MARE(g) reporters (right) in the absence/presence of cotransfected exogenous c-Fos. Luciferase activity was measured 48 hr after transfection.
(C) Competitive transactivation assays of MafB (wt)/c-Fos and MafB (E269R)/c-Fos with T-MARE(g)-Firefly- and T-MARE(b)-Renilla-luciferase reporters
cotransfected in the same cells. Error bars correspond to SD.
Structure
MafB/c-Fos Assembly-Induced DNA Binding Profilebinding to homodimer-promoting T-MARE(g) sites versus heter-
odimer-promoting T-MARE(b) sites.
Perspectives
During recent years, regulated systems for gene transcription
have been increasingly employed to alter genetic programs
and associated functional readouts, such as signaling andmeta-
bolic pathways (Kiel et al., 2010; Lim, 2010; Tigges and Fusse-
negger, 2009). In this contribution, we show that, using two
structures of the same bZip transcription factor MafB either
assembled as a homodimer or as a heterodimer with another
bZip transcription factor c-Fos, it is possible to change the
balance of MafB2 homodimer and MafB/c-Fos heterodimer for-
mation on the same T-MARE sequence by targeted mutations
in the respective leucine zippers. We also show that it is possible
to change the binding preference for different T-MARE variants,
as shown for the MafB (E269R) mutant. In general terms, our
findings thus could provide innovative tools to control specific
gene expression by selectively activating homo- or hetero-
dimer-specific binding repertoires and signaling pathways. As
the basic principles of coiled-coil protein/protein interactions
are common to all bZip transcription factors, our procedures
could be applicable to other members of this transcription factor
family, to the extent that the DNA-recognition motifs of partner
bZip transcriptions factors differ. Engineered MafB dimerization
may ultimately enable the precise understanding and controlled
manipulation of distinct activity states and binding repertoires of474 Structure 22, 466–477, March 4, 2014 ª2014 Elsevier Ltd All righMafB, in particular in macrophages, with therapeutic potential
in infectious disease, inflammatory or autoimmune disorders,
regeneration, and tumor biology.EXPERIMENTAL PROCEDURES
MafB2/T-MARE and MafB/c-Fos/T-MARE(b) Purification and
Crystallization
The C-terminal region of MafB fromMus musculus (residues 211–305; C298S)
was purified as previously described (Textor et al., 2007). Homodimeric MafB2
complexes were dialyzed overnight into 30mMTris-HCl (pH 7.3), 80 mMNaCl,
50 mM MgCl2, and 3 mM b-mercaptoethanol at room temperature in the
presence of an oligonucleotide encompassing the T-MARE-binding site
(sequences in Table S1). The protein-DNA complex was further purified by
size exclusion chromatography on a Superdex-75 (16/60) column (GE), equil-
ibrated with the dialysis buffer. The pooled peak fractions corresponding to the
(MafB)2/T-MARE complex were analyzed by SDS-PAGE and native PAGE
gels and concentrated to 5 mg/mL, using a centrifugal concentrator with a
polyethersulfone membrane with a 10,000 molecular weight cut off (MWCO;
VIVASPIN, Sartorius Stedim Biotech). Crystallization drops of 400 nL volume,
using a 1:1 protein/mother liquor ratio, were set up in 96-well sitting-drop
plates and allowed to equilibrate at 19C. Diffracting crystals grew in the pres-
ence of 0.1 M Na-citrate (pH 5.0), 15% (w/v) polyethylene glycol (PEG)-4000,
5% (v/v) PEG-400, and 0.1 M MgCl2.
For structural investigations of heterodimeric MafB/c-Fos complexes, a
c-Fos fragment from Mus musculus (residues 138–200), encompassing the
BR and Zip segment, was cloned in the pET-M11 vector and expressed in
the Escherichia coli strain BL21(DE3)RIL. Cell pellets with overexpressed
MafB and c-Fos were lysed separately under denaturing conditions in 4 M
urea, 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 15 mM b-mercaptoethanol.ts reserved
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MafB/c-Fos Assembly-Induced DNA Binding ProfileThe proteins were separately purified on a nickel nitrilotriacetic acid affinity
column (QIAGEN). The heterodimer was refolded upon dialysis against a buffer
containing 150 mM NaCl, 15 mM Tris (pH 7.5), and 10 mM dithiothreitol, in the
presence of the chemically synthesized cognate DNA duplex T-MARE(b)
(sequences in Table S1) and the tobacco etch virus protease in a mass ratio
of 1:25 to remove the hexa-histidine tag. TheMafB/c-Fos/T-MARE(b) complex
was further purified by exclusion chromatography on a Superdex 75 column,
equilibrated with the same buffer. Finally, theMafB/c-Fos/T-MARE(b) complex
was concentrated up to 15 mg/mL, using a centrifugal concentrator with a
polyethersulfone membrane with a 10,000 MWCO (VIVASPIN, Sartorius
Stedim Biotech). Hanging drop crystallization trials were carried out at 20C,
by mixing equal volumes of reservoir solution and MafB/c-Fos/T-MARE(b)
complex solution. Crystals grew from 0.075 M 4-(2-hydroxyethyl)-1-piperazi-
neethanesulfonic-acid-Na (pH 7.5), 0.6 M sodium dihydrogen phosphate,
0.6 M potassium dihydrogen phosphate, 25% (v/v) glycerol.
MafBmutants were generated with theQuikChange Site-DirectedMutagen-
esis Kit (Stratagene). Primers of 45 bp were designed to introduce single mu-
tations in MafB. MafB mutants were expressed and purified as the wt protein.
X-Ray Structure Determination
MafB2/T-MARE
Crystals were cryoprotected by briefly soaking them into a solution used for
crystallization, which included in addition 20% (w/v) PEG-400. A native X-ray
data set was collected to a resolution of 2.9 A˚ on beamline ID23-2 at the
European Synchotron Radiation Facility (ESRF) in Grenoble, France. The
data were processed in the orthorhombic Laue group P222with the XDS pack-
age (Kabsch, 2010). The structure was solved by molecular replacement in
space group P22121 with the program PHASER (McCoy, 2007), applying the
coordinates of one MafB protomer (residues 212–253) bound to the CRE-
like MARE (C-MARE) half-site from the MafB2/C-MARE complex (Protein
Data Bank accession number 4AUW) as the search model. The remaining pro-
tein residues and the DNA bases were built manually using the program COOT
(Emsley and Cowtan, 2004) and successive cycles of restrained refinement
with the program REFMAC5 (Murshudov et al., 1997). One cycle of simulated
annealing was applied to the built model using the program PHENIX (Adams
et al., 2011). The atomic coordinates were further refined to a final Rwork
and Rfree of 23.5% and 27.5%, respectively, using a noncrystallographic
symmetry restraint (Table 1). Ordered solvent molecules were added to the
protein model, using the program ARP/wARP (Laskowski et al., 1998). The
quality of the homodimeric MafB structure was validated using the program
PROCHECK (Laskowski et al., 1993).
MafB/c-Fos/T-MARE(b)
All crystals used for X-ray data collection were mounted from themother liquor
onto a cryo-loop (Hampton Research) and directly flash-cooled under the
nitrogen beam at 100K. X-ray data were collected on the synchrotron radiation
beamlines BW7A and X11 at the DORIS III ring at EMBL/DESY in Hamburg,
Germany. Experimental phases were determined from an X-ray data set to a
maximum resolution of 3.2 A˚, using the single-wavelength anomalous disper-
sion technique. For this purpose, crystals were derivatized with iodine using
the vaporizing-iodine-labeling technique (Miyatake et al., 2006), by placing a
small drop of 0.67 M KI/0.47 M I2 solution next to the crystallization drop for
6 hr. The protein was weakly derivatized by this process, which together
with the anomalous scattering from the DNA phosphate backbone provided
sufficient phasing information by the identification of a total of 24 heavy
atom sites to solve the structure using a combination of SHELX and SHARP
programs (Bricogne et al., 2003; Schneider and Sheldrick, 2002). In addition,
a native data set of the MafB/c-Fos/T-MARE(b) complex was collected to a
resolution of 2.1 A˚. The data set was processed with MOSFLM (Leslie and
Powell, 2007) and programs of the CCP4 suite (CCP4, 1994). Further X-ray
data collection and experimental phasing statistics are listed in Table 1.
Phase-extension was used to combine the experimentally determined
phases with a high-resolution (2.3 A˚) native data set. The final model was
built with COOT (Emsley and Cowtan, 2004) and refined with the program
REFMAC5 (Murshudov et al., 1997) to a final Rwork and Rfree of 22.8% and
25.6%, respectively. The asymmetric unit contains one MafB/c-Fos/DNA
complex. The statistics of the structure refinement are summarized in Table 1.
The stereochemical quality of the model was assessed by use of the program
PROCHEK (Laskowski et al., 1993).Structure 22,In the structure of the MafB2/T-MARE complex, all DNA bases and the com-
plete polypeptide chains, except one terminal residue of one of the two MafB
molecules (F211) are visible. In the structure of the MafB/c-Fos/T-MARE(b)
complex, the complete T-MARE(b) motif as well as the complete c-Fos and
MafB polypeptide chains are visible, except tree residues from the N terminus
(F211-D213) and two residues from the C terminus (S304-G305) of the ex-
pressed MafB fragment. The coordinates of the MafB2/MARE(a) and MafB/
c-Fos/MARE(b) complexes have been deposited in the Protein Data Bank
with respective accession numbers 2WTY and 2WT7.
EMSA
Double-stranded synthetic oligonucleotides corresponding to T-MARE(a), to
T-MARE(b), and to T-MARE(g) (sequences in Table S1) sites were incubated
with Klenow fragment DNA polymerase in the presence of [a32P]CTP and
purified on Qiaquick Spin Columns (QIAGEN). For c-Fos titration in presence
of a constant amount of MafB, increasing amounts (0.25, 0.5, 1, 2, 4, 8, 16,
32, and 64 pmol) of recombinant c-Fos and recombinant protein (4 pmol) of
MafB (wt) or MafB (E269R) and MafB (V277N) mutants were incubated with
0.05 ng of probe in 20 ml of binding reaction buffer (20 mM Tris-HCl [pH 7.5],
100 mM KCl, 0.1 mM EDTA, 5% glycerol, 0.1% Triton X-100, 0.02% BSA,
0.5 mg poly d[I-C]) for 20 min. For MafB titration in absence of c-Fos,
increasing amounts (0.25, 0.5, 1, 2, 4, 8, 16, 32, and 64 pmol) of wt or mutant
MafB proteins were incubated with 0.05 ng of probe in 20 ml of binding reaction
buffer. Complexes formedwere resolved on a 6%polyacrylamide (acrylamide/
bisacrylamide ratio, 29:1) nondenaturating gel (Bio-Rad) in 0.5% Tris-glycine.
Gels were dried and autoradiographed at 80C.
Coimmunoprecipitation
MafB-deficient Maf double knockout (DKO) macrophages (Aziz et al., 2009)
were transduced with indicated combinations of empty, c-Fos and MafB
(wt), or MafB (E269R) and MafB (V277N) mutant encoding pMSCV vector
using previously described infection protocols (Aziz et al., 2009). Cells were
lysed in RIPA buffer (50 mM Tris-HCl [pH 8], 150 mM NaCl, 1% NP-40,
0.5% sodium deoxycholate, 0.1% SDS, protease inhibitors) and incubated
for 30 min at 4C. After clearing by centrifugation, lysates were incubated
with the Flag-M2 antibody conjugated to agarose (Sigma, F2426) or with
the anti-c-Fos antibody (Santa Cruz, sc-7202), previously coupled with pro-
tein A/G. After incubation, pellets were collected by centrifugation and
washed four times in washing buffer (50 mM Tris-HCl [pH 8], 150 mM NaCl,
protease inhibitors). Bound proteins were eluted with 62.5 mM Tris-HCl
(pH 6.8), 2% SDS, 10% glycerol, and 0.002% bromophenol blue. Western
blot detection was done by standard methods using anti-c-Fos (Santa Cruz,
sc-7202) or anti-Flag-horseradish-peroxidase conjugated antibody (Sigma,
A8592), respectively.
Transient Transfection and Reporter Gene Assay
Human embryonic kidney 293 (HEK293) cells were grown in Dulbecco’s modi-
fied Eagle’s medium supplemented with 10% fetal bovine serum in six-well
plates to reach 60%–80% confluence at the time of transfection. DNA was
transfected by calcium phosphate precipitation procedure as previously
described (Sieweke et al., 1996). pTK81 luciferase reporter constructs
(200 ng; Promega) containing three multimerized T-MARE(a), T-MARE(b), or
T-MARE(g) (sequences in Table S1) were cotransfected with 200 ng of
pRc/CMV (Invitrogen) constructs driving the expression of wt, and mutant
full-length MafB with or without 200 ng of pRc/CMV construct driving the
expression of c-Fos or no transgene (vector control). Assays were performed
in duplicate. The transfection efficiency was normalized by assaying for
b-galactosidase activity from a cotransfected pCMV-LacZ construct, and
luciferase activity was analyzed as previously described (Sieweke et al.,
1996). For the competitive luciferase assay, Firefly luciferase gene down-
stream of T-MARE(g) was excised using the BglII and XbaI sites and has
been replaced by the Renilla luciferase gene. A total of 100 ng of pTK81-T-
MARE(b)-Firefly and 100 ng of pTK81-T-MARE(g)-Renilla were cotransfected
with 200 ng of pRc/CMV or 200 ng of pRc/CMV-3X-Flag-MafB expression vec-
tor or with both MafB and c-Fos expression vector (200 ng each) by phosphate
calcium precipitation. The transfection efficiency was normalized, by assaying
for b-galactosidase activity from a cotransfected pCMV-LacZ construct, and
luciferase activity was analyzed using a dual-luciferase reporter assay system466–477, March 4, 2014 ª2014 Elsevier Ltd All rights reserved 475
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MafB/c-Fos Assembly-Induced DNA Binding Profilekit (Promega, catalog number E1910) according to the manufacturer’s
recommendations.
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